134 related articles for article (PubMed ID: 9706062)
41. Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study.
Hawwa AF; Westwood PM; Collier PS; Millership JS; Yakkundi S; Thurley G; Shields MD; Nunn AJ; Halliday HL; McElnay JC
Br J Clin Pharmacol; 2013 May; 75(5):1265-76. PubMed ID: 23016949
[TBL] [Abstract][Full Text] [Related]
42. Plasma pharmacokinetics of ranitidine HCl in foals.
Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
[TBL] [Abstract][Full Text] [Related]
43. Effect of acute hyperglycemia on basal and cholecystokinin stimulated exocrine pancreatic secretion in humans.
Lam WF; Masclee AA; de Boer SY; Souverijn JH; Lamers CB
Life Sci; 1997; 60(24):2183-90. PubMed ID: 9188761
[TBL] [Abstract][Full Text] [Related]
44. Effect of Sustained Elevated Gastric pH Levels on Gefitinib Exposure.
Tang W; Tomkinson H; Masson E
Clin Pharmacol Drug Dev; 2017 Sep; 6(5):517-523. PubMed ID: 28176470
[TBL] [Abstract][Full Text] [Related]
45. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
[TBL] [Abstract][Full Text] [Related]
46. Simultaneous determination of amoxicillin and ranitidine in rat plasma by high-performance liquid chromatography.
Li W; Tan F; Zhao K
J Pharm Biomed Anal; 2006 May; 41(2):594-8. PubMed ID: 16364584
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of oral ranitidine in Mexicans.
Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V; Herrera-Abarca A; Pérez-Urizar J; Herrera JE; Hong E
Arch Med Res; 1996; 27(3):349-52. PubMed ID: 8854394
[TBL] [Abstract][Full Text] [Related]
48. Site-dependent small intestinal absorption of ranitidine.
Gramatté T; el Desoky E; Klotz U
Eur J Clin Pharmacol; 1994; 46(3):253-9. PubMed ID: 8070507
[TBL] [Abstract][Full Text] [Related]
49. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
Leucuţa A; Vlase L; Farcau D; Nanulescu M
Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
[TBL] [Abstract][Full Text] [Related]
51. Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet.
Hodges LA; Sime KA; Creech LA; Connolly SM; Barclay ST; Kwon MC; Jeon BJ; Shim SM; Wang HS; Stevens HN; Park JS
Int J Pharm; 2013 Sep; 454(1):41-6. PubMed ID: 23834829
[TBL] [Abstract][Full Text] [Related]
52. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
[TBL] [Abstract][Full Text] [Related]
53. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.
Ashiru DA; Patel R; Basit AW
Pharm Res; 2008 Oct; 25(10):2327-33. PubMed ID: 18600434
[TBL] [Abstract][Full Text] [Related]
54. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.
Suttle AB; Pollack GM; Brouwer KL
Pharm Res; 1992 Mar; 9(3):350-6. PubMed ID: 1614968
[TBL] [Abstract][Full Text] [Related]
55. Plasma pharmacokinetics of ranitidine HCl in adult horses.
Holland PS; Ruoff WW; Brumbaugh GW; Brown SA
J Vet Pharmacol Ther; 1997 Apr; 20(2):145-52. PubMed ID: 9131542
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog.
Parr AF; Sandefer EP; Wissel P; McCartney M; McClain C; Ryo UY; Digenis GA
Pharm Res; 1999 Feb; 16(2):266-71. PubMed ID: 10100313
[TBL] [Abstract][Full Text] [Related]
57. Gastrokinetic activity of Morinda citrifolia aqueous fruit extract and its possible mechanism of action in human and rat models.
Nima S; Kasiwong S; Ridtitid W; Thaenmanee N; Mahattanadul S
J Ethnopharmacol; 2012 Jul; 142(2):354-61. PubMed ID: 22580040
[TBL] [Abstract][Full Text] [Related]
58. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
59. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
[TBL] [Abstract][Full Text] [Related]
60. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
Bendas ER; Ayres JW
Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
